Recent studies have expanded the roles of AMPK in a variety of metabolic syndromes, such as obesity, type 2 diabetes, fatty liver syndrome, cardiovascular diseases, and tumorigenesis. This evidence concerns the gene PRKAA1 and obesity disorder.